Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed |
|---|---|---|
|
CureVac N.V.
13D/A
Amendment 1
CVAC · N2451R105
|
0% |
12/5/2025
Event 12/3/2025
|
|
CureVac N.V.
13D
CVAC · N2451R105
|
74.0% |
8/13/2025
Event 8/7/2025
|
|
Spero Therapeutics, Inc.
13D/A
Amendment 9
SPRO · 84833T103
|
16.4% |
3/28/2025
Event 3/27/2025
|